Consolidated Statements of Cash Flows - USD ($)	1 Months Ended	11 Months Ended	12 Months Ended
	Jan. 23, 2018	Dec. 31, 2018	Dec. 31, 2019
Cash flows from operating activities:
Net loss		$ (3,842,186)	$ (11,870,228)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation		1,329,074	590,041
Changes in operating assets and liabilities:
Prepaid assets		(12,065)	(1,080,397)
Accounts payable	(1,833)	(398,189)	12,449
Accrued research and development expense			1,132,013
Net cash used in operating activities	(1,833)	(2,126,988)	(11,216,122)
Cash flows from investing activities:
Net cash used in investing activities
Cash flows from financing activities:
Net transfers from parent	1,833
Payment of offering costs		(97,312)
Net proceeds from issuance of common stock in connection with IPO			21,851,160
Net proceeds from issuance of preferred stock		12,485,971	7,198,227
Net cash provided by financing activities	1,833	12,388,659	29,049,387
Net increase in cash and cash equivalents		10,261,671	17,833,265
Cash and cash equivalents at beginning of period			10,261,671
Cash and cash equivalents at end of period		10,261,671	28,094,936
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to former parent for acquired assets		4,000
Accrued offering costs		30,456
Accrued dividend		728,350	875,359
Conversion of Series A Preferred Stock (including accrued dividends) to common stock			21,287,907
Offering costs netted with proceeds from IPO			97,312
Deemed dividend for beneficial conversion feature of Series A Preferred Stock			$ 23,929,751